Drug application
LEVOLEUCOVORIN CALCIUM (LEVOLEUCOVORIN CALCIUM)
Drugs@FDA ANDA 206263 · HIKMA PHARMS
Key facts
| Drug name | LEVOLEUCOVORIN CALCIUM |
|---|---|
| Active ingredients | LEVOLEUCOVORIN CALCIUM |
| Application type | ANDA |
| Application number | 206263 |
| Company | HIKMA PHARMS |
| Dosage forms | POWDER, INTRAVENOUS |
| Strength | EQ 50MG BASE/VIAL |
| Marketing status | Discontinued |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Jun 16, 2016 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- 1–9 Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
- No FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: